摘要 |
There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R 34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
|
申请人 |
GLAXO GROUP LIMITED |
发明人 |
REDGRAVE, ALISON JUDITH;REDFERN, TRACY JANE;EVANS, BRIAN;GOUGH, SHARON LISA;LUNNISS, CHRISTOPHER JAMES;ROBINSON, JOHN EDWARD;WOODROW, MICHAEL;GUNTRIP, STEPHEN BARRY;HAMBLIN, JULIE NICOLE;HOLMAN, STUART;BALDWIN, IAN ROBERT;BARKER, MICHAEL DAVID;DEAN, ANTHONY WILLIAM;ELDRED, COLIN DAVID;LINDVALL, MIKA KRISTIAN;JONES, PAUL |